The soluble form of ST2 acts as a decoy receptor that inhibits the cardioprotective effects of IL‐33, leading to cardiac hypertrophy, myocardial fibrosis, and ventricular dysfunction, and be used to assess the severity and prognosis of heart failure.14 Here, IL1RL1 is linked to heart failure.